NIMA Partners

Coming – September 8

Making Meals Safer For 27 Million Americans

Date and Time

September 8

–

12:00 PM ET / 9:00 AM PT

Details will be shared with confirmed attendees

About this Event

For millions of people with celiac disease and other medical conditions requiring them to avoid gluten, eating at a restaurant or trying an unfamiliar food can come with an uncomfortable question: Is this actually safe for me to eat?

NIMA is putting the answer in the palm of their hands in the form of a handheld sensor that can test a food sample for gluten contamination in approximately three minutes with 99% accuracy. Consumers simply place a small sample into a disposable testing capsule, insert it into the NIMA sensor and receive a result before eating.

Every test contributes to NIMA’s growing database of restaurants and foods, creating a crowdsourced food safety intelligence network that becomes more valuable as more people use it. NIMA ultimately plans to expand its platform beyond gluten to additional allergens, potentially including peanuts and dairy.

NIMA reports strong early commercial traction, including $3.4 million in annual recurring revenue, thousands of sensors in use, high customer retention and strong customer satisfaction. Its recurring revenue model is driven by ongoing purchases of disposable testing capsules, while longer-term opportunities include subscriptions, restaurant certification, food ratings, employer and university programs, and B2B data products.

Join us for an executive briefing with Mike Glick, CEO of NIMA, to learn how the company is building a personal food safety platform designed to give consumers greater confidence in what they eat.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.